Telegra Alternatives for Telehealth Brands

What problem should a Telegra alternative solve?

Telegra’s official platform spans commerce, patient experience and operating tools. It also publishes CSV migration documentation. Those are meaningful capabilities to acknowledge when building a shortlist rather than claiming a replacement uniquely offers a portal or patient imports.

Start with the reason for reviewing alternatives. A different mobile experience, more configuration control, a different clinical arrangement or changed commercial terms can each justify a different shortlist. The TEHR versus Telegra comparison examines those scope and pricing questions in detail.

For an existing brand, compare the value of retaining a familiar patient experience with the benefit of changing the operating model. A portal replacement creates training and communication work even when it improves the interface. Conversely, preserving the interface will not solve a clinical or administrative problem unless the underlying responsibilities change.

Which operating models belong on the shortlist?

This shortlist groups different operating models. The order is editorial, with TEHR first, and does not represent independent testing or numerical scores. Vendor statements are presented as of October 22, 2026; a missing public detail means it needs confirmation, not that the capability is absent.

When is TEHR the right alternative to evaluate?

TEHR combines white-label technology and administrative infrastructure with an independent licensed clinical network reaching all 50 states, subject to program, state and patient eligibility. It supports clinician e-prescribing, pharmacy coordination, AI-assisted intake, payments and subscriptions. Clinical decisions remain with independent licensed providers. Its commercial model is a flat platform subscription plus flat transaction fee and 0% revenue share; contact TEHR for a scoped quote. See the platform and pricing scope.

TEHR is worth evaluating when you want an operator-led plan for the commercial and administrative side of a health brand, connected to independent clinical services. Ask it to demonstrate the continuing-patient journey and to scope migration around the records and subscriptions you actually have. Its flat-fee structure should be compared with complete written terms, not with Telegra’s onboarding installments treated as recurring subscription pricing.

Trade-off: Confirm the actual clinical, pharmacy, support and integration scope before treating a platform proposal as an all-inclusive service. Patients see the brand, while required notices still identify the real care entities. Selected peptide programs are pending and are not open for prescribing or fulfillment.

When should you consider Bask Health?

Strength: Bask’s plans page describes storefront, patient portal, EMR/e-prescribing, provider access and pharmacy fulfillment. Its current Core/Growth/Enterprise labels differ from a July 31, 2026 article describing Mini/Growth/Enterprise, so the public packaging should be reconciled before buying. Official plans and pricing; Plan comparison, July 31, 2026.

Consider Bask when your team wants a configurable DTC experience with clinical and pharmacy connections. Resolve its current public plan inconsistency before comparing features and costs. Ask how the proposed portal, subscriptions and operational tools would replace or preserve the patient experience you already run.

Trade-off: Obtain the current written rate card instead of combining features and prices from conflicting pages. Confirm plan-specific access to integrations and support. Its documented clinical and pharmacy connections mean it should not be described as merely a storefront builder.

When should you consider OpenLoop?

Strength: OpenLoop’s Launchpad describes a no-code website, branded portal, intake, clinicians and operating workflows. The current product is broader than a clinician network; its official page also describes integration into existing customer systems. Official launchpad and platform.

Consider OpenLoop when you want a fuller turnkey operating arrangement and a connected platform. Its Launchpad documentation includes patient-facing and back-office components. Ask which services are included in the proposed contract and how your team would request changes after go-live, especially for continuing programs and recurring orders.

Trade-off: The reviewed page does not establish a universal numeric rate card or revenue-share policy. Request itemized terms and identify the work your team retains. Treat its fastest launch statement as a vendor estimate with readiness conditions, not a migration guarantee.

When should you consider Cuvo Health?

Strength: Cuvo’s pricing page publishes platform plans and a completed-consult charge, explicitly states no revenue share or added platform transaction fee, and describes patient/data migration without an additional migration charge. It also distinguishes full-platform plans from its existing-stack Prescribe option. Official pricing.

Consider Cuvo when published plans and a stated migration offer make procurement easier to evaluate. Compare setup, recurring and clinical costs with the same assumptions used for Telegra. Clarify the record types and operating support included in migration rather than assuming an advertised service covers every clinical or billing dependency.

Trade-off: Include setup, recurring and clinical charges in the comparison; standard payment-processing and other delivery costs still matter. A clinical connection to an existing stack has different dependencies from building a full brand. Confirm what its migration offer covers for your actual records.

When should you consider CareValidate?

Strength: CareValidate describes integrated white-label infrastructure and a nationwide provider network. Its laboratory page outlines both at-home kits and in-person orders, with results connected to charts and provider workflows. Its launch materials describe managed patient support and existing-stack API connectivity. Official provider network; Labs and diagnostics.

Consider CareValidate when laboratory workflows and coordinated administrative support are important to the intended program. Ask to see the patient and operator experience around a delayed or abnormal result, with clear clinical escalation. The public integration story is a starting point for scoping, not a substitute for a complete proposal.

Trade-off: Request an itemized fee schedule and migration scope; neither was established on the reviewed public pages. Confirm which support tasks and lab costs are included. A broadly integrated offering still needs a clear handoff when a patient needs clinical rather than administrative help. Launch telehealth.

When should you consider Beluga Health?

Strength: Beluga offers direct API, hosted intake and platform-partner configurations. Its pricing page explicitly describes no cut of customer revenue, flat monthly access, per-visit fees and pharmacy/lab pass-through with disclosed service charges. Dollar amounts are quoted during scoping. Official platform integration paths; Pricing.

Consider Beluga when you want to separate clinical infrastructure from the commerce and portal layer. This can preserve a product your team prefers or support a new independent experience. Be explicit about which company handles subscriptions, messaging and support so the modular architecture does not leave recurring work unassigned.

Trade-off: Determine which company supplies commerce, subscriptions and patient support in your chosen configuration. A clinical backend can be the right fit for an existing stack, but its fee alone should not be compared with the price of a complete commercial operation.

When should you consider Lithos Health?

Strength: Lithos describes a white-label medical practice delivered through an API while customers build their own product. Its pricing page publishes per-completed-visit bands, and its migration page describes staged transitions with parallel testing and clinical continuity work. Official practice infrastructure; Pricing.

Consider Lithos when a developer-led product is the intended destination. Its clinical practice API and public migration guidance can support that architecture, but your team continues to own the customer product. Include the engineering and operational effort of replacing an integrated portal, rather than comparing only clinical visit prices.

Trade-off: The brand must account for building and operating the customer-facing product. Compare the appropriate modality and graduated volume bands, not only the lowest advertised visit rate. Public migration guidance is useful, but your source records and program still determine the plan. Migration.

When should you consider FUSE Health?

Strength: FUSE describes white-label storefront, intake, portal, payments and operational infrastructure with different support levels. Its pricing page labels a percentage-based merchant service fee and contains inconsistent DIY monthly amounts between plan cards and FAQ text. Confirm the current written terms. Official how it works; Pricing.

Consider FUSE when you want to choose how much of brand construction and launch is managed for you. Its support levels and fee model need to be matched to your internal resources. Resolve the current DIY price inconsistency and model the stated merchant service charge before comparing total economics.

Trade-off: Model the merchant service fee using the vendor’s terminology, separately from payment processing and clinical costs. Do not recast it as an independently verified revenue-share contract. Decide whether you want self-service configuration or managed implementation before comparing launch packages.

How should you narrow the shortlist?

Define the minimum patient experience you must preserve. That may include access to messages, clear order history, recurring billing controls and reliable instructions about the next clinical step. If a mobile app is central, confirm plan-specific availability and maintenance; if patients mainly use the web, avoid buying an app merely because it is prominent in a demo.

Then compare the operator experience. Can support understand what is pending without interpreting medical information? Can the right team resolve a failed payment, a fulfillment delay or a requested clinical follow-up? Ask finalists to demonstrate those cases using a realistic recurring journey rather than a first checkout alone.

Review TEHR pricing alongside each current written proposal. Onboarding payments, platform subscriptions, clinical charges and payment-processing fees have different purposes. A fair model keeps those categories separate and includes the cost of the work your own staff will continue to perform.

How should existing patients move to the chosen platform?

Telegra’s documented import capability does not establish the outbound export scope for your own account. Request authorized samples and map patient identifiers across clinical records, commerce and subscriptions. Determine what must be retained in the original system and what must be accessible to the receiving team.

The Telegra migration guide and migration checklist help plan the cutover. Test clinical continuity and recurring billing separately, then together. Patient communications should explain the practical change, required actions and support route without suggesting that a new interface changes independent clinical judgment.

What should the final proposal make explicit?

Ask for the service boundaries, itemized charges, implementation dependencies and operational acceptance criteria in writing. Review the white-label telehealth guide if the proposals use the same label for different scopes, and use the resource library to prepare program and migration questions. A good shortlist should become a small set of comparable proposals. It should not end as a ranking that hides unanswered questions about who supplies care, who performs administrative work and what the brand will actually pay.

For a wider category view, compare the white-label telehealth platform shortlist and the turnkey telehealth platform shortlist. Use the first to examine brand and architecture choices, and the second to assess which implementation and operating tasks a proposed package actually supplies.

What else should you know?